The Journal of Antibiotics

Academic journal

The Journal of Antibiotics

Discipline| Microbiology
Language| English
Edited by| Kuniaki Tatsuta
Publication details
History| 1948–present
Publisher|

Nature Publishing Group

Frequency| Monthly

Impact factor

| 3.424 (2021)
Standard abbreviations
ISO 4 (alt) * Bluebook (alt1 * alt2)
NLM (alt) * MathSciNet (alt )
ISO 4| J. Antibiot.
NLM| J Antibiot (Tokyo)
Indexing
CODEN (alt * alt2) * JSTOR (alt) * LCCN (alt)
MIAR * NLM (alt) * Scopus
CODEN| JANTAJ
ISSN| 0021-8820 (print)
1881-1469 (web)

OCLC no.| 01642415
Links

* Journal homepage
* Archive 2005–2020 (vol. 58–73)
* Archive 1968–2004 (vol. 21–57)

The Journal of Antibiotics is a peer-reviewed medical journal published by the Nature Publishing Group for the Japan Antibiotics Research Association.

The journal seeks to endorse studies on antibiotics and associated types of biologically-active substances.

In June 2020, the journal published a pioneer systematic review on ivermectin and COVID-19 by Fatemeh Heiday and Reza Gharebaghi which has become highly cited.[1]

## References[edit]

1. ^ Heidary, Fatemeh; Gharebaghi, Reza (2020). "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen". The Journal of Antibiotics. 73 (9): 593–602. doi:10.1038/s41429-020-0336-z. ISSN 0021-8820. PMC 7290143. PMID 32533071.

## External links[edit]

* Official website

This article about a microbiology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

|

* v
* t
* e

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template